Abstract:Background: Postoperative paralytic ileus (POI) is a significant concern following gastrointestinal tumor surgery. Effective preventive and therapeutic strategies are crucial but remain elusive. Current evidence from randomized-controlled trials on pharmacological interventions for prevention or treatment of POI are systematically reviewed to guide clinical practice and future research. Materials and Methods: Literature was systematically searched for prospective randomized-controlled trials testing pharmacological interventions for prevention or treatment of POI after gastrointestinal tumor surgery. Meta-analysis was performed using a random effects model to determine risk ratios and mean differences with 95% confidence intervals. Risk of bias and evidence quality were assessed. Results: Results from 55 studies, involving 5078 patients who received experimental interventions, indicate that approaches of opioid-sparing analgesia, peripheral opioid antagonism, reduction of sympathetic hyperreactivity, and early use of laxatives effectively prevent POI. Perioperative oral Alvimopan or intravenous administration of Lidocaine or Dexmedetomidine, while safe regarding cardio-pulmonary complications, demonstrated effectiveness concerning various aspects of postoperative bowel recovery (Lidocaine: -5.97 [-7.20 – -4.74]h, P <0.0001; Dexmedetomidine: -13.00 [-24.87 – -1.14]h, P =0.03 for time to first defecation; Alvimopan: -15.33 [-21.22 – -9.44]h, P <0.0001 for time to GI-2 ) and length of hospitalization (Lidocaine: -0.67 [-1.24 – -0.09]d, P =0.02; Dexmedetomidine: -1.28 [-1.96 – -0.60]d, P =0.0002; Alvimopan: -0.58 [-0.84 – -0.32]d, P <0.0001) across wide ranges of evidence quality. Perioperative non-opioid analgesic use showed efficacy concerning bowel recovery as well as length of hospitalization (-1.29 [-1.95 – -0.62]d, P =0.0001). Laxatives showed efficacy regarding bowel movements, but not food tolerance and hospitalization. Evidence supporting pharmacological treatment for clinically evident POI is limited. Results from one single study suggest that Neostigmine reduces time to flatus and accelerates bowel movements (-37.06 [-40.26 – -33.87]h, P <0.0001 and -42.97 [-47.60 – -38.35]h, P <0.0001, respectively) with low evidence quality. Conclusion: Current evidence concerning pharmacological prevention and treatment of POI following gastrointestinal tumor surgery is limited. Opioid-sparing concepts, reduction of sympathetic hyperreactivity, and laxatives should be implemented into multimodal perioperative approaches.

Postoperative ileus—Immune mechanisms and potential therapeutic interventions

Molecular mechanisms of postoperative ileus following gastrointestinal surgery

Molecular and Cellular Mechanisms Underlying Postoperative Paralytic Ileus by Various Immune Cell Types

Postoperative Ileus and Postoperative Gastrointestinal Tract Dysfunction: Pathogenic Mechanisms and Novel Treatment Strategies Beyond Colorectal Enhanced Recovery After Surgery Protocols

Inflammation and Impaired Gut Physiology in Post-operative Ileus: Mechanisms and the Treatment Options

Post-operative ileus: definitions, mechanisms and controversies

Pathophysiology and Management of Postoperative Ileus in Adults and Neonates: A Review

Postoperative Ileus Murine Model

Global research trends in postoperative ileus from 2011 to 2023: A scientometric study

An outline of the management and prevention of postoperative ileus: A review

Postoperative Ileus after Minimally Invasive Colorectal Surgery: A Summary of Current Strategies for Prevention and Management

Controlling postoperative ileus by vagal activation

Pharmacologic prevention and therapy of postoperative paralytic ileus after gastrointestinal cancer surgery – systematic review and meta-analysis

Involvement of Inos-Induced Reactive Enteric Glia Cells in Gastrointestinal Motility Disorders of Postoperative Ileus Mice.

Altered Intestinal Permeability and Drug Repositioning in a Post-operative Ileus Guinea Pig Model

Progress in Study on Mechanism and Management of Postoperative Ileus Caused by Morphine

Research progress in nutrition support treatment for postoperative ileus

[Advances in the Prevention and Treatment of Postoperative Ileus].

Postoperative ileus-Establishing a porcine model

Alterations of Prostanoid Expression and Intestinal Epithelial Barrier Functions in Ileus

CCR2-dependent monocyte-derived macrophages resolve inflammation and restore gut motility in postoperative ileus